Fredun Pharmaceuticals buys 26% of Goodman Vetcare to enter veterinary retail
Fredun Pharmaceuticals has acquired a 26% stake in Goodman Vetcare, gaining access to its veterinary retail and pet-care network. The move follows Fredun’s acquisition of USV’s pet-wellness brand Furlicks earlier this month.
What happened
Fredun Pharmaceuticals acquired a 26% stake in Goodman Vetcare, expanding into veterinary retail and pet care through Goodman’s established network. Earlier
Key facts
- 26% stake
- ₹1.51 crore combined SEBI settlement
- ₹76.05 lakh
- ₹45.50 lakh
- ₹9.75 lakh each
Why this matters
Fredun is using a buy-and-partner strategy to enter pet care, combining brand ownership with network access rather than pursuing a full veterinary-retail acquisition.
What to watch
- Announcement of Furlicks availability across Goodman Vetcare locations or e-commerce channels.
- Disclosure of board representation, commercial agreements, exclusivity provisions, or an option to raise Fredun's stake.
- New Fredun pet-care product launches, veterinary approvals, or companion-animal manufacturing investments.
- Goodman store/clinic expansion, franchise additions, or growth in veterinary consultations.
- Further pet-care M&A by Fredun, especially in diagnostics, supplements, pharmacy, or veterinary services.
- Evidence that the partnership lifts sales, repeat purchases, or veterinarian recommendation rates.
- Launch Furlicks or Fredun-developed pet-wellness products through Goodman Vetcare clinics, stores, and digital channels.
- Negotiate distribution, co-marketing, data-sharing, and preferred-supplier agreements with Goodman.
- Build a broader companion-animal portfolio through acquisitions, licensing, or contract manufacturing.
- Add veterinary-focused field sales, practitioner education, and preventive-care marketing capabilities.
- Consider raising the Goodman stake or pursuing other clinic, diagnostics, grooming, or pet-pharmacy partnerships.